We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr Strikes Back At Celgene In Thalomid Spat

Law360 (October 11, 2007, 12:00 AM EDT) -- Barr Laboratories has fired back at Celgene Corp. in a patent suit over the market for Celgene's cancer treatment Thalomid, alleging that Celgene's patents are invalid and accusing Celgene of violating...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.